Scavilla Daniel T
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Scavilla Daniel T. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| XRAY | President, CEO & Member of BOD | Award / Grant | 224 | — | — | Oct 10, 2025 |
| XRAY | Award / Grant | 210 | — | — | Jul 11, 2025 | |
| XRAY | Award / Grant | 13,880 | — | — | May 22, 2025 | |
| XRAY | Award / Grant | 3,385 | — | — | Feb 24, 2025 | |
| GMED | President, CEO | Sale | 130,000 | $85.00 | $11,050,000 | Nov 21, 2024 |
| GMED | President, CEO | Option Exercise | 30,000 | $26.27 | $788,100 | Nov 6, 2024 |
| GMED | EVP, Chief Commercial Officer | Sale | 400 | $78.97 | $31,588 | Jul 2, 2021 |
| GMED | EVP, Chief Commercial Officer | Sale | 100,000 | $55.09 | $5,509,000 | May 21, 2020 |
| GMED | Senior VP and CFO | Option Exercise | 18,210 | $25.40 | $462,534 | Apr 10, 2018 |